Adial Pharmaceuticals, Inc. (ADIL) Ownership

$0.45

$0 (-0.95%)
Last update: 04:00 PM EST
Day's range
$0.43
Day's range
$0.46

Adial Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 68.85 K $43.66 K   11.32% 0.37%
MANCHESTER CAPITAL MANAGEMENT LLC 05/09/2025 48.10 K $30.50 K   0.00% 0.26%
UBS GROUP AG 05/13/2025 47.75 K $30.27 K   127.16% 0.26%
BLACKROCK, INC. 05/02/2025 27.77 K $17.61 K   0.00% 0.15%
VIRTU FINANCIAL LLC 05/12/2025 26.41 K $17.00 K   100.00% 0.14%
VANGUARD GROUP INC 05/09/2025 13.16 K $8.34 K   100.00% 0.07%
1620 INVESTMENT ADVISORS, INC. 05/14/2025 3.60 K $2.28 K   0.00% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 1.43 K $905   123.67% 0.01%
05/02/2025 927 $588   -1.07% 0.01%
WELLS FARGO & COMPANY/MN 05/13/2025 160 $101   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/15/2025 55 $35   5.77% 0.00%
ABOUND WEALTH MANAGEMENT 04/17/2025 27 $18   0.00% 0.00%
MORGAN STANLEY 05/15/2025 9 $6   0.00% 0.00%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 0 $0   -100.00% 0.00%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 04/22/2025 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 05/15/2025 0 $0   -100.00% 0.00%

Adial Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 18 institutional investors and hedge funds held shares of Adial Pharmaceuticals, Inc.. The most heavily invested institutionals were:

GEODE CAPITAL MANAGEMENT, LLC: 68,850

Manchester Capital Management LLC: 48,097

UBS Group AG: 47,745

BlackRock, Inc.: 27,770

Virtu Financial LLC: 26,414

VANGUARD GROUP INC: 13,159

1.28% of Adial Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 280.98 K shares in the last 24 months. This purchase volume represents approximately $126.02 K in transactions.